BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29467231)

  • 1. Diagnostic accuracy of computed tomography to identify adenomas among adrenal incidentalomas in an endocrinological population.
    Marty M; Gaye D; Perez P; Auder C; Nunes ML; Ferriere A; Haissaguerre M; Tabarin A
    Eur J Endocrinol; 2018 May; 178(5):439-446. PubMed ID: 29467231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenal wash-out CT: moderate diagnostic value in distinguishing benign from malignant adrenal masses.
    Schloetelburg W; Ebert I; Petritsch B; Weng AM; Dischinger U; Kircher S; Buck AK; Bley TA; Deutschbein T; Fassnacht M
    Eur J Endocrinol; 2021 Dec; 186(2):183-193. PubMed ID: 34813495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adrenocortical carcinomas and adrenal pheochromocytomas: mass and enhancement loss evaluation at delayed contrast-enhanced CT.
    Szolar DH; Korobkin M; Reittner P; Berghold A; Bauernhofer T; Trummer H; Schoellnast H; Preidler KW; Samonigg H
    Radiology; 2005 Feb; 234(2):479-85. PubMed ID: 15671003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of adrenal adenoma and nonadenoma in unenhanced CT: new optimal threshold value and the usefulness of size criteria for differentiation.
    Park SH; Kim MJ; Kim JH; Lim JS; Kim KW
    Korean J Radiol; 2007; 8(4):328-35. PubMed ID: 17673844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT Characteristics of Pheochromocytoma: Relevance for the Evaluation of Adrenal Incidentaloma.
    Canu L; Van Hemert JAW; Kerstens MN; Hartman RP; Khanna A; Kraljevic I; Kastelan D; Badiu C; Ambroziak U; Tabarin A; Haissaguerre M; Buitenwerf E; Visser A; Mannelli M; Arlt W; Chortis V; Bourdeau I; Gagnon N; Buchy M; Borson-Chazot F; Deutschbein T; Fassnacht M; Hubalewska-Dydejczyk A; Motyka M; Rzepka E; Casey RT; Challis BG; Quinkler M; Vroonen L; Spyroglou A; Beuschlein F; Lamas C; Young WF; Bancos I; Timmers HJLM
    J Clin Endocrinol Metab; 2019 Feb; 104(2):312-318. PubMed ID: 30383267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
    Sane T; Schalin-Jäntti C; Raade M
    J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation of adrenal adenomas from nonadenomas using CT attenuation values.
    Korobkin M; Brodeur FJ; Yutzy GG; Francis IR; Quint LE; Dunnick NR; Kazerooni EA
    AJR Am J Roentgenol; 1996 Mar; 166(3):531-6. PubMed ID: 8623622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Quantitative MRI and CT Washout Analysis for Differentiation of Adrenal Pheochromocytoma From Adrenal Adenoma.
    Schieda N; Alrashed A; Flood TA; Samji K; Shabana W; McInnes MD
    AJR Am J Roentgenol; 2016 Jun; 206(6):1141-8. PubMed ID: 27011100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of adrenal lesions using MDCT wash-out parameters: diagnostic accuracy of several combinations of intermediate and delayed phases.
    Foti G; Malleo G; Faccioli N; Guerriero A; Furlani L; Carbognin G
    Radiol Med; 2018 Nov; 123(11):833-840. PubMed ID: 29923085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentiation of adrenal adenomas from nonadenomas using CT histogram analysis method: a prospective study.
    Halefoglu AM; Bas N; Yasar A; Basak M
    Eur J Radiol; 2010 Mar; 73(3):643-51. PubMed ID: 19167179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinguishing benign from malignant adrenal masses: multi-detector row CT protocol with 10-minute delay.
    Blake MA; Kalra MK; Sweeney AT; Lucey BC; Maher MM; Sahani DV; Halpern EF; Mueller PR; Hahn PF; Boland GW
    Radiology; 2006 Feb; 238(2):578-85. PubMed ID: 16371582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinguishing adrenal adenomas from non-adenomas with multidetector CT: evaluation of percentage washout values at a short time delay triphasic enhanced CT.
    Liu T; Sun H; Zhang H; Duan J; Hu Y; Xie S
    Br J Radiol; 2019 Feb; 92(1094):20180429. PubMed ID: 30433826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adrenal Adenoma and Pheochromocytoma: Comparison of Multidetector CT Venous Enhancement Levels and Washout Characteristics.
    Northcutt BG; Trakhtenbroit MA; Gomez EN; Fishman EK; Johnson PT
    J Comput Assist Tomogr; 2016; 40(2):194-200. PubMed ID: 26978001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MDCT of adrenal masses: Can dual-phase enhancement patterns be used to differentiate adenoma and pheochromocytoma?
    Northcutt BG; Raman SP; Long C; Oshmyansky AR; Siegelman SS; Fishman EK; Johnson PT
    AJR Am J Roentgenol; 2013 Oct; 201(4):834-9. PubMed ID: 24059372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic performance of adrenal CT in the differentiation of adenoma and pheochromocytoma.
    Altinmakas E; Perrier ND; Grubbs EG; Lee JE; Prieto VG; Ng CS
    Acta Radiol; 2020 Aug; 61(8):1080-1086. PubMed ID: 31791129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Preoperative Biochemical Testing for Pheochromocytoma Necessary for All Adrenal Incidentalomas?
    Jun JH; Ahn HJ; Lee SM; Kim JA; Park BK; Kim JS; Kim JH
    Medicine (Baltimore); 2015 Nov; 94(45):e1948. PubMed ID: 26559265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-density pheochromocytoma on CT: a mimicker of adrenal adenoma.
    Blake MA; Krishnamoorthy SK; Boland GW; Sweeney AT; Pitman MB; Harisinghani M; Mueller PR; Hahn PF
    AJR Am J Roentgenol; 2003 Dec; 181(6):1663-8. PubMed ID: 14627592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors.
    Ohno Y; Sone M; Taura D; Yamasaki T; Kojima K; Honda-Kohmo K; Fukuda Y; Matsuo K; Fujii T; Yasoda A; Ogawa O; Inagaki N
    Hypertens Res; 2018 Mar; 41(3):165-175. PubMed ID: 29348428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unenhanced CT imaging is highly sensitive to exclude pheochromocytoma: a multicenter study.
    Buitenwerf E; Korteweg T; Visser A; Haag CMSC; Feelders RA; Timmers HJLM; Canu L; Haak HR; Bisschop PHLT; Eekhoff EMW; Corssmit EPM; Krak NC; Rasenberg E; van den Bergh J; Stoker J; Greuter MJW; Dullaart RPF; Links TP; Kerstens MN
    Eur J Endocrinol; 2018 May; 178(5):431-437. PubMed ID: 29467230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pheochromocytomas Versus Adenoma: Role of Venous Phase CT Enhancement.
    Mohammed MF; ElBanna KY; Ferguson D; Harris A; Khosa F
    AJR Am J Roentgenol; 2018 May; 210(5):1073-1078. PubMed ID: 29570377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.